Biotechnology News

October 14, 2014

BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq:SGEN) announced today that it will report its third quarter 2014 financial results on Thursday, October 30, 2014 after the close of financial markets. Following the announcement,...

October 14, 2014

NORTH BETHESDA, Md.--(BUSINESS WIRE)--The 505(b)(2) Forum is scheduled for Oct. 27 during the Generic Pharmaceutical Association (GPhA) Fall Technical Conference in North Bethesda, MD.

October 14, 2014

DAVIS, Calif.--(BUSINESS WIRE)--Arcadia Biosciences, an agricultural technology company focused on developing agricultural products that benefit the environment and enhance human health, announced today it was named in the prestigious 2014 Global...

October 14, 2014

SAN ANTONIO--(BUSINESS WIRE)--Convergent Dental Inc. announced that Solea™ was awarded DrBicuspid.com’s Dental Excellence Award at ADA 2014 in San Antonio, TX.

October 14, 2014

LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist to Announce Third Quarter 2014 Financial Results on Tuesday, October 21, 2014

October 14, 2014

FARMINGTON, Conn.--(BUSINESS WIRE)--Independent agency Primacy today announced that it has teamed up with 3000 Miles to a Cure to develop a Google Glass application for Race Across America (RAAM), which will help to raise money for brain cancer...

October 14, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--German biotech company sphingotec GmbH is out-licensing its breast cancer biomarker test to GeneNews Limited, and the test will soon be available from GeneNews Limited's U.S. joint venture.

October 14, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq:ALNY), a leading RNAi therapeutics company, announced today that it presented new data from multiple clinical and pre-clinical studies at the 10th Annual Meeting of the...

October 14, 2014

NEW YORK--(BUSINESS WIRE)--Retrophin, Inc. (NASDAQ:RTRX) today announced that it has reached an agreement to divest non-core assets ketamine, Syntocinon Nasal Spray® (oxytocin), and Vecamyl® (mecamylamine HCI tablets) to Turing Pharmaceuticals....

October 14, 2014

BURLINGTON, Mass.--(BUSINESS WIRE)--Dyax Corp. (NASDAQ:DYAX) will host a webcast and conference call, including an open question and answer session, Tuesday, October 28, 2014. During the call, management will discuss the Company’s financial...

October 14, 2014

BEDFORD, Mass.--(BUSINESS WIRE)--Ocular Therapeutix, Inc. (Nasdaq: OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, today announced that Amar...

October 14, 2014

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Quintiles receives the 2014 Eagle Award from the SCRS

October 14, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Acceleron Pharma (NASDAQ: XLRN), has initiated a phase 1 clinical trial of its novel, locally administered muscle drug, ACE-083. Fourth internally discovered drug expands clinical pipeline.

October 14, 2014

ZUG, Switzerland--(BUSINESS WIRE)--Foster Wheeler AG (NASDAQ:FWLT) announced today that a subsidiary of its Global Engineering and Construction Group has been awarded a contract by PEMEX REFINACIÓN for an ultra-low sulfur diesel (ULSD) project at...

October 14, 2014

NEW YORK--(BUSINESS WIRE)--Nanotronics Imaging, developer of the world’s most technologically advanced nanoimaging solutions, today introduced its latest computer-controlled microscope, the nSPEC® 3D, at the American Chemical Society 2014...

October 14, 2014

MENLO PARK, Calif.--(BUSINESS WIRE)--Personalis, a leading genomics-based clinical diagnostic laboratory, has been awarded a contract to provide ACE Clinical Exome™ testing for genetic disorders by the US Department of Veterans Affairs.

October 14, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aberrant growth and the accumulation of biomass are hallmarks of cancer. Raze targets newly identified pathways that are essential to this anabolic metabolism and tumor survival.

October 14, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (Nasdaq: BLUE) a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic and orphan diseases, today announced that the first subject with...

October 14, 2014

DUBLIN--(BUSINESS WIRE)--Mallinckrodt plc (NYSE: MNK), a leading global specialty biopharmaceutical company, today announced financial guidance for its fiscal year ending September 25, 2015. For fiscal 2015, Mallinckrodt’s annual net sales are...

October 14, 2014

LUXEMBOURG & HONG KONG--(BUSINESS WIRE)--ABL, The University of Honk Kong and The Hong Kong Polytechnic University collaborate to a deep-sequencing assay and a tailored bioinformatics pipeline for enabling early and improved diagnosis of TB...

October 14, 2014

SEATTLE--(BUSINESS WIRE)--Kineta, Inc., a biotechnology company focused on the development of immune modulating drugs for critical diseases, announced today that the company has opened a Phase 1B proof-of-concept clinical trial for psoriasis...

October 14, 2014

STOCKHOLM--(BUSINESS WIRE)--Mölnlycke Health Care today announces results from a study that demonstrates that an active, self-warming blanket (BARRIER® EasyWarm®) is equally effective as forced-air warming in preventing hypothermia in mid-...

October 13, 2014

GAINESVILLE, Fla.--(BUSINESS WIRE)--Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, will release its third quarter 2014 financial results on...

October 13, 2014

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Model N, Inc. (NYSE: MODN), the leader in Revenue Management Cloud solutions to the life science and technology industries, plans to announce financial results for the fourth quarter and fiscal year 2014...

October 13, 2014

PARSIPPANY, N.J.--(BUSINESS WIRE)--Pacira Pharmaceuticals, Inc. Announces Additional Data Supporting Safety of EXPAREL® in Peripheral Nerve Block

October 13, 2014

DURHAM, N.C.--(BUSINESS WIRE)--bioMérieux’s VITEK® MS system Nominated for Prestigious 2014 U.S. Prix Galien Award: First FDA-Cleared Diagnostic Instrument to Utilize MALDI-TOF Mass Spectrometry to Rapidly Identify Harmful Bact

October 13, 2014

ROCHESTER, N.Y.--(BUSINESS WIRE)--Experienced Lab Manager Brings Extensive Professional and Regional Knowledge to ACM Global’s Newest Lab Facility

October 13, 2014

HOLLISTON, Mass.--(BUSINESS WIRE)--Molecular Templates has entered into a Preferred Provider Agreement with Veristat for Refractory non-Hodgkin’s B-Cell Lymphoma trial.

October 13, 2014

EVRY, France--(BUSINESS WIRE)--Regulatory News: Global Bioenergies (Paris:ALGBE) carries out a new draw down on the equity line signed on May 16th, 2014 with Yorkville Advisors. Global Bioenergies issues 2,700 new shares individually priced at 38...

October 13, 2014

BOULDER, Colo.--(BUSINESS WIRE)--SomaLogic Announces Agreement to Place SOMAscan™ Proteomics Assay in NIH Center for Human Immunology, Autoimmunity and Inflammation

October 13, 2014

DURHAM, N.C.--(BUSINESS WIRE)--Bioventus Acquires OsteoAMP from Advanced Biologics.

October 13, 2014

TUCSON, Ariz.--(BUSINESS WIRE)--BioVigilant's new IMD-W(TM) instantaneous microbial detection system delivers new tool for real-time bioburden control of pharmaceutical waters.

October 13, 2014

HAYWARD, Calif.--(BUSINESS WIRE)--Pharmatech Associates has appointed veteran regulatory expert Richard Aleman as VP of Regulatory Compliance.

October 13, 2014

HAYWARD, Calif.--(BUSINESS WIRE)--Pharmatech Associates has appointed Warren G. Baker as CEO. Calvin Wong, Pharmatech's founder and original CEO, will serve as chairman of the advisory board.

October 13, 2014

BARCELONA, Spain & SEOUL, South Korea--(BUSINESS WIRE)--The Vall d’Hebron Research Institute in Spain, and Genomics services company Macrogen in Seoul, signed a comprehensive Genomics service partnership agreement including Macrogen X-Genome...

October 13, 2014

NEW YORK--(BUSINESS WIRE)--Bristol Myers Squibb to Hold Investor Teleconference to Discuss CMSTO Highlights

October 13, 2014

PORT ST. LUCIE, Fla.--(BUSINESS WIRE)--VGTI Florida launches its new Center for Diseases of Aging in collaboration with Sweden's Karolinska Institute, perhaps best known for annually awarding the Nobel Prize in Medicine.

October 13, 2014

MILAN--(BUSINESS WIRE)--Sorin Group announces results of the Perceval CAVALIER Trial and the Pooled European Multicenter Experience at the 28th Annual Meeting of the European Association for Cardio-Thoracic Surgery (EACTS).

October 13, 2014

SAN DIEGO--(BUSINESS WIRE)--Cosmederm Bioscience has announced that UK-based Woodford Investment Management is investing $50 million into the company.

October 13, 2014

PARIS--(BUSINESS WIRE)--Stem cells hold great promise for treating a variety of human diseases and injuries. Basic and translational stem cell research is among the most competitive fields in the life sciences. We have co-organized the first...

October 13, 2014

COLUMBIA, Md.--(BUSINESS WIRE)--Osiris Therapeutics Announces Third Quarter 2014 Financial Results Conference Call

October 13, 2014

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. today announced the New Drug Application (NDA) for palbociclib has been accepted for filing and granted Priority Review by the United States Food and Drug Administration (FDA). This NDA requests FDA approval...

October 13, 2014

NEW YORK & SUNNYVALE, Calif. & RARITAN, N.J.--(BUSINESS WIRE)--Bristol-Myers Squibb, Pharmacyclics and Janssen Announce Clinical Collaboration to Evaluate OPDIVO® (nivolumab) and IMBRUVICA®(ibrutinib) in Non-Hodgkin Lymphoma

October 13, 2014

LEXINGTON, Mass.--(BUSINESS WIRE)--Concert presented CTP-354 Phase 1 clinical results at the American Neurological Association Annual Meeting. CTP-354 is a potential treatment for spasticity.

October 13, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq:ALNY), a leading RNAi therapeutics company, announced today six-month clinical data from its ongoing Phase 2 open-label extension (OLE) study with patisiran (ALN-TTR02), an...

October 13, 2014

ZHANGJIAJIE, China--(BUSINESS WIRE)--Jinchi Biotech Ltd. announced that ‘The Giant Salamander Glycopeptides in Resisting Skin Photo-aging Clinical Research’ has been published in ‘Chinese Medical Cosmetology’ Periodical (Volume 4, Issue 3, 2014...

October 13, 2014

TOULOUSE, France--(BUSINESS WIRE)--Regulatory News: VEXIM (Paris:ALVXM) (FR0011072602 – ALVXM / Eligible PEA-PME), a medical device company specializing in the minimally invasive treatment of vertebral fractures, today announced it will initiate...